David D. Chang - 16 Mar 2026 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Reporting relationship: President and CEO, Director
Issuer ticker: ALLO
Reported as of: 16 Mar 2026
Net transaction value: -$117,975
SEC form: 4
Accepted by SEC: 18 Mar 2026, 16:05:48 UTC
Prior SEC filing: 04 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/Earl Douglas, Attorney-in-Fact

Key filing fact

David D. Chang filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 18 Mar 2026.

Key facts

This page summarizes David D. Chang's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 16:05.

Change

Previous filing in this sequence was filed on 04 Feb 2026.
Current net transaction value: -$117,975.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001611024 Primary reporting owner

Chang David D

Relationship: President and CEO, Director
Address: 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Signature: /s/Earl Douglas, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLO transaction

Common Stock

Sale

Transaction value: $117,975
Shares: -47,763
Change %: -0.92%
Price: $2.47
Shares after: 5,150,599
Date: 16 Mar 2026
Ownership: Direct
Footnotes: F1, F2

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 856,044
Date: 16 Mar 2026
Ownership: See footnote
Footnotes: F3

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 856,044
Date: 16 Mar 2026
Ownership: See footnote
Footnotes: F4

ALLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,201,108
Date: 16 Mar 2026
Ownership: See footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

1. Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Footnote F2

3. Includes 12,500 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.

Footnote F3

Securities held in the name of the RTC 2019 Trust dated October 1, 2019.

Footnote F4

Securities held in the name of the JEC 2019 Trust dated October 1, 2019.

Footnote F5

Securities held in the name of the Chang 2006 Family Trust